Exagen Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
/ 
Frequently asked questions
To buy Exagen Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Exagen Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Exagen Inc. is XGN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Exagen Inc. has its primary listing on NASDAQ. You can trade Exagen Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Exagen Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Exagen Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Exagen Inc. or others.